×

Stocks Pfizer Inc

  • Markets rose on Friday after fluctuating in a tight range throughout the session after a weak open on Friday. How should investors be positioned going forward? Peter Costa, president of Empire Executions and CNBC market analyst and Richard Regan, founder and managing partner at Protradingcourse.com shared their insights.

  • Earnings season kicked off with a thud on Monday as Alcoa missed on revenue for the first time since 2007. However, analysts expect earnings to be decent overall. Tom Lydon, editor of ETF Trends and David Dietze, president and chief investment strategist at Point View Financial Services shared their insights.

  • Crude oil will hit $100 a barrel while gold will reach $1,500 an ounce by the end of this year, said Byron Wien, vice chairman of Blackstone Advisory Services.

  • Stocks slipped Wednesday after a senior Fed member said policy makers should start raising rates to 1 percent soon.

  • Stocks slipped Wednesday after a senior Fed member said policy makers should start raising rates to 1 percent soon.

  • greenspan_140.jpg

    Former chairman of the Federal Reserve Alan Greenspan reinforced increasingly confident assessments by the Obama administration that the nation’s latest job numbers reveal a resurgent economy.

  • Jeff Kindler, Pfizer Chairman and CEO

    The world’s largest drug company, Pfizer, has handled mergers badly, invented too few drugs and left its reputation in disrepair after two criminal cases.  And that is the assessment of its own chief executive. The NYT talks to Pfizer CEO Jeffrey Kindler.

  • Now that the markets closed 4% or higher for the quarter, a positive first quarter is a good indication for the year where historically the Dow, S&P and NASDAQ Composite have managed to post average gains of more than 12% in the year when Q1 was a positive quarter versus average losses of -0.2% or greater when Q1 was negative.

  • Stocks pulled off a gain Tuesday after a see-saw session as techs and industrials gained, while energy and bank stocks were weak.

  • 100_bills_stacked.jpg

    Companies are increasingly sharing their record cash hoard with investors, and that trend should accelerate with a new wave of increased dividends and buybacks this quarter, according to a report from an investment bank.

  • Miles White

    You need to buy the paper edition for $5 or subscribe to the website to see it for yourself, but Barron's has put only one biopharma honcho on its annual list of the world's top-30 CEOs.

  • Markets wavered on Friday after a better-than-expected reading on consumer sentiment. How should investors position their portfolios going forward? Bob Auer, portfolio manager at Auer Growth Fund, Jerry Castellini, president and CIO of CastleArk Management, and Mark Freeman, portfolio manager at WHG Funds, discussed their insights.

  • Stocks pushed higher Friday after a slightly better-than-expected reading on consumer sentiment. Stocks had gotten off to a higher start after the EU and IMF reached a deal to provide a safety net for Greece.

  • After traders celebrated what was cynically dubbed “Dow 10k 2.0” just 5.5 months ago, the Dow Industrials is now just a small hop away from regaining the 11,000 level. Once it reaches that level, the Dow will have rallied 68 percent from its March 2009 low.

  • Stocks ended sharply higher Tuesday after a late rally as investors cheered a better-than-expected existing-home sales report. The Dow gained over 100 points, led by Kraft and Pfizer. Health insurers gave back some of its gains after the prior session's rally.

  • The Dow is now up 10 out of 11 days and within striking distance of 11,000. Will the melt-up propel us over this milestone?

  • Stocks pushed higher Tuesday after a $44 billion two-year note auction and a better-than-expected existing-home sales report. Health care gave back some of its gains after the prior session's rally.

  • Stocks advanced Tuesday after a report showed existing-home sales fell less than expected last month but health care gave back some of its gains after the prior session's rally.

  • Stocks ended higher Monday, led by health care, as passage of the health-care bill lifted uncertainty surrounding the legislation that was hanging over the market. Citigroup jumped after an analyst upgrade.

  • Stocks bounced back from a lower open Monday as all the uncertainty surrounding the health bill lifted after the House approved it. Merck and Pfizer remained at the front of the Dow pack. Citigroup jumped after an analyst upgrade.